188 related articles for article (PubMed ID: 35698591)
1. The Combination of Betahistine and Oxybutynin Increases Respiratory Control Sensitivity (Loop Gain) in People with Obstructive Sleep Apnea: A Randomized, Placebo-Controlled Trial.
Messineo L; Loffler K; Chiang A; Osman A; Taranto-Montemurro L; Eckert DJ
Nat Sci Sleep; 2022; 14():1063-1074. PubMed ID: 35698591
[TBL] [Abstract][Full Text] [Related]
2. Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity.
Aishah A; Lim R; Sands SA; Taranto-Montemurro L; Wellman A; Carberry JC; Eckert DJ
J Appl Physiol (1985); 2021 May; 130(5):1373-1382. PubMed ID: 33734828
[TBL] [Abstract][Full Text] [Related]
3. Addition of zolpidem to combination therapy with atomoxetine-oxybutynin increases sleep efficiency and the respiratory arousal threshold in obstructive sleep apnoea: A randomized trial.
Messineo L; Carter SG; Taranto-Montemurro L; Chiang A; Vakulin A; Adams RJ; Carberry JC; Eckert DJ
Respirology; 2021 Sep; 26(9):878-886. PubMed ID: 34164887
[TBL] [Abstract][Full Text] [Related]
4. Zolpidem increases sleep efficiency and the respiratory arousal threshold without changing sleep apnoea severity and pharyngeal muscle activity.
Messineo L; Eckert DJ; Lim R; Chiang A; Azarbarzin A; Carter SG; Carberry JC
J Physiol; 2020 Oct; 598(20):4681-4692. PubMed ID: 32864734
[TBL] [Abstract][Full Text] [Related]
5. The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial.
Altree TJ; Aishah A; Loffler KA; Grunstein RR; Eckert DJ
J Clin Sleep Med; 2023 Jan; 19(1):85-96. PubMed ID: 36004739
[TBL] [Abstract][Full Text] [Related]
6. The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomised crossover trial.
Lim R; Messineo L; Grunstein RR; Carberry JC; Eckert DJ
J Physiol; 2021 Sep; 599(17):4183-4195. PubMed ID: 34174090
[TBL] [Abstract][Full Text] [Related]
7. Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits.
Taranto-Montemurro L; Messineo L; Azarbarzin A; Vena D; Hess LB; Calianese NA; White DP; Wellman A; Sands SA
Chest; 2020 Jun; 157(6):1626-1636. PubMed ID: 32006590
[TBL] [Abstract][Full Text] [Related]
8. Randomized Trial on the Effects of High-Dose Zopiclone on OSA Severity, Upper Airway Physiology, and Alertness.
Carter SG; Carberry JC; Grunstein RR; Eckert DJ
Chest; 2020 Jul; 158(1):374-385. PubMed ID: 32197956
[TBL] [Abstract][Full Text] [Related]
9. One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial.
Aishah A; Loffler KA; Toson B; Mukherjee S; Adams RJ; Altree TJ; Ainge-Allen HW; Yee BJ; Grunstein RR; Carberry JC; Eckert DJ
Ann Am Thorac Soc; 2023 Apr; 20(4):584-595. PubMed ID: 36538809
[No Abstract] [Full Text] [Related]
10. Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial.
Perger E; Taranto Montemurro L; Rosa D; Vicini S; Marconi M; Zanotti L; Meriggi P; Azarbarzin A; Sands SA; Wellman A; Lombardi C; Parati G
Chest; 2022 Jan; 161(1):237-247. PubMed ID: 34543665
[TBL] [Abstract][Full Text] [Related]
11. A single dose of noradrenergic/serotonergic reuptake inhibitors combined with an antimuscarinic does not improve obstructive sleep apnoea severity.
Thomson LDJ; Landry SA; Joosten SA; Mann DL; Wong AM; Cheung T; Adam M; Beatty CJ; Hamilton GS; Edwards BA
Physiol Rep; 2022 Aug; 10(16):e15440. PubMed ID: 36029192
[TBL] [Abstract][Full Text] [Related]
12. Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway.
Corser B; Eves E; Warren-McCormick J; Rucosky G
J Clin Sleep Med; 2023 Jun; 19(6):1035-1042. PubMed ID: 36734173
[TBL] [Abstract][Full Text] [Related]
13. A novel TASK channel antagonist nasal spray reduces sleep apnea severity in physiological responders: a randomized, blinded, trial.
Osman AM; Toson B; Naik GR; Mukherjee S; Delbeck M; Hahn M; Muller T; Weimann G; Eckert DJ
Am J Physiol Heart Circ Physiol; 2024 Mar; 326(3):H715-H723. PubMed ID: 38214905
[TBL] [Abstract][Full Text] [Related]
14. The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial.
Taranto-Montemurro L; Messineo L; Sands SA; Azarbarzin A; Marques M; Edwards BA; Eckert DJ; White DP; Wellman A
Am J Respir Crit Care Med; 2019 May; 199(10):1267-1276. PubMed ID: 30395486
[No Abstract] [Full Text] [Related]
15. Effect of oxybutynin and reboxetine on obstructive sleep apnea: a randomized, placebo-controlled, double-blind, crossover trial.
Berger M; Solelhac G; Marchi NA; Dussez R; Bradley B; Lecciso G; Heiniger G; Bayon V; Van Den Broecke S; Haba-Rubio J; Siclari F; Heinzer R
Sleep; 2023 Jul; 46(7):. PubMed ID: 36861433
[TBL] [Abstract][Full Text] [Related]
16. A Novel Model to Estimate Key Obstructive Sleep Apnea Endotypes from Standard Polysomnography and Clinical Data and Their Contribution to Obstructive Sleep Apnea Severity.
Dutta R; Delaney G; Toson B; Jordan AS; White DP; Wellman A; Eckert DJ
Ann Am Thorac Soc; 2021 Apr; 18(4):656-667. PubMed ID: 33064953
[No Abstract] [Full Text] [Related]
17. Zopiclone Increases the Arousal Threshold without Impairing Genioglossus Activity in Obstructive Sleep Apnea.
Carter SG; Berger MS; Carberry JC; Bilston LE; Butler JE; Tong BK; Martins RT; Fisher LP; McKenzie DK; Grunstein RR; Eckert DJ
Sleep; 2016 Apr; 39(4):757-66. PubMed ID: 26715227
[TBL] [Abstract][Full Text] [Related]
18. Drug therapy for obstructive sleep apnoea in adults.
Mason M; Welsh EJ; Smith I
Cochrane Database Syst Rev; 2013 May; (5):CD003002. PubMed ID: 23728641
[TBL] [Abstract][Full Text] [Related]
19. Effects of morphine on respiratory load detection, load magnitude perception, and tactile sensation in obstructive sleep apnea.
Tomazini Martins R; Carberry JC; Gandevia SC; Butler JE; Eckert DJ
J Appl Physiol (1985); 2018 Aug; 125(2):393-400. PubMed ID: 29698106
[TBL] [Abstract][Full Text] [Related]
20. Stepwise Add-On and Endotype-informed Targeted Combination Therapy to Treat Obstructive Sleep Apnea: A Proof-of-Concept Study.
Aishah A; Tong BKY; Osman AM; Pitcher G; Donegan M; Kwan BCH; Brown E; Altree TJ; Adams R; Mukherjee S; Eckert DJ
Ann Am Thorac Soc; 2023 Sep; 20(9):1316-1325. PubMed ID: 37159953
[No Abstract] [Full Text] [Related]
[Next] [New Search]
